Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of 4-Methylbenzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.55 |
| ▸ | DRD1 known ✓ | P21728 | 1/20 | 0.55 |
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.54 |
| ▸ | HDAC1 known ✓ | Q13547 | 1/20 | 0.52 |
| ▸ | HDAC6 known ✓ | Q9UBN7 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.94 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.94 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.81 |
| ▸ | TSHR | P16473 | 3/20 | 0.67 |
| ▸ | TP53 | P04637 | 1/20 | 0.67 |
| ▸ | CES2 | O00748 | 2/20 | 0.62 |
| ▸ | CES1 | P23141 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | RXRA | P19793 | 1/20 | 0.58 |
| ▸ | RXRB | P28702 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA3 | P07451 | 1/20 | 0.55 |
| ▸ | TYR | P14679 | 1/20 | 0.55 |
| ▸ | CA4 | P22748 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4-Methylbenzoic Acid SCHEMBL28013046 | 0.97 | ALDH1A1 (0.90) | ALDH1A1SMN1; SMN2SRD5A2TSHRTP53 | |
| 4-Methylbenzoic Acid SCHEMBL11366477 | 0.97 | ALDH1A1 (1.00) | ALDH1A1SMN1; SMN2SRD5A2TSHRTP53 | |
| Terephthalic Acid SCHEMBL526449 | 0.97 | ALDH1A1 (1.00) | ALDH1A1SMN1; SMN2SRD5A2TSHRTP53 | |
| 4-Methylbenzoic Acid SCHEMBL147465 | 0.97 | ALDH1A1 (1.00) | ALDH1A1SMN1; SMN2SRD5A2TSHRTP53 | |
| Terephthalic Acid SCHEMBL15994097 | 0.97 | ALDH1A1 (1.00) | ALDH1A1SMN1; SMN2SRD5A2TSHRTP53 | |
| 4-Methylbenzoic Acid SCHEMBL1331178 | 0.97 | ALDH1A1 (1.00) | ALDH1A1SMN1; SMN2SRD5A2TSHRTP53 | |
| 4-Methylbenzoic Acid SCHEMBL93638 | 0.97 | ALDH1A1 (1.00) | ALDH1A1SMN1; SMN2SRD5A2TSHRTP53 | |
| 4-Methylbenzoic Acid SCHEMBL27860985 | 0.95 | ALDH1A1 (0.85) | ALDH1A1SMN1; SMN2SRD5A2TSHRTP53 | |
| 4-Methylbenzoic Acid SCHEMBL28297064 | 0.95 | ALDH1A1 (0.85) | ALDH1A1SMN1; SMN2SRD5A2TSHRTP53 | |
| 4-Methylbenzoic Acid SCHEMBL1150904 | 0.94 | ALDH1A1 (0.94) | ALDH1A1SMN1; SMN2SRD5A2TSHRTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2621891-A1 | POLYMORPHS OF 4-[2-DIMETHYLAMINO-1-(1-HYDROXYCYCLOHEXYL)ETHYL]PHENYL 4-METHYLBENZOATE HYDROCHLORIDE, METHODS FOR PREPARING THE SAME AND USE OF THE SAME | Shan Dong Luye Pharmaceutical Co., Ltd. (CN) | 2013-08-07 | — | — | EP | claimed |
| WO-2012041013-A1 | POLYMORPHS OF 4-[2-DIMETHYLAMINO-1-(1-HYDROXYCYCLOHEXYL)ETHYL]PHENYL 4-METHYLBENZOATE HYDROCHLORIDE, METHODS FOR PREPARING THE SAME AND USE OF THE SAME | SHAN DONG LUYE PHARMACEUTICAL CO., LTD. (CN) | 2012-04-05 | — | — | WO | claimed |
| EP-3921349-B1 | PHENYL ISOCYANATE CONVERSION PROCESS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-14 | — | — | EP | disclosed |
| EP-3689849-B1 | PERFUME PRECURSOR | TAKASAGO PERFUMERY CO LTD (JP) | 2025-01-15 | — | — | EP | disclosed |
| US-12030836-B2 | Phenyl isocyanate conversion process | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-07-09 | — | — | US | disclosed |
| CN-113474388-B | Method for converting phenyl isocyanate | 陶氏环球技术有限责任公司 | 2024-03-22 | — | — | CN | disclosed |
| US-11802258-B2 | Perfume precursor | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-10-31 | — | — | US | disclosed |
| WO-2022091938-A1 | METHOD FOR PRODUCING SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, METHOD FOR PRODUCING CATALYST FOR OLEFIN POLYMERIZATION, AND METHOD FOR PRODUCING OLEFIN POLYMER | 東邦チタニウム株式会社 | 2022-05-05 | — | — | WO | disclosed |
| US-11306053-B2 | Ester compound and lubricating oil base oil | DAISAN KASEI CO., LTD (JP) | 2022-04-19 | — | — | US | disclosed |
| US-20220106264-A1 | PHENYL ISOCYANATE CONVERSION PROCESS | DOW GLOBAL TECHNOLOGIES LLC | 2022-04-07 | — | — | US | disclosed |
| EP-3921349-A1 | PHENYL ISOCYANATE CONVERSION PROCESS | Dow Global Technologies LLC (US) | 2021-12-15 | — | — | EP | disclosed |
| US-4329456-A | ACYLATION WITHOUT INTERMEDIATE ISOLATION | CIBA-GEIGY AG (CH) | 1982-05-11 | — | — | US | disclosed |
| EP-0044635-A1 | Catalyst components for polymerization of alpha-olefins and a method for using them | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1982-01-27 | — | — | EP | disclosed |
| US-4294777-A | ADDING AN ALDEHYDE, KETONE, OLEFIN, ORGANOPHOSPHORUS OR ORGANOARSENIC COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 1981-10-13 | — | — | US | disclosed |
| US-4179436-A | DYEING POLYESTERS | BAYER AKTIENGESELLSCHAFT (DE) | 1979-12-18 | — | — | US | disclosed |
| US-4135045-A | PROCESS FOR POLYMERIZATION OF OLEFINS AND CATALYST COMPOSITION THEREFOR | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1979-01-16 | — | — | US | disclosed |
| US-4120884-A | Storage-stable, liquid polyisocyanates possessing carbodiimide groups, and process for their manufacture | BASF AKTIENGESELLSCHAFT (DE) | 1978-10-17 | — | — | US | disclosed |
| US-4048415-A | TITANIUM-ALUMINUM COORDINATION CATALYSTS | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JA) | 1977-09-13 | — | — | US | disclosed |
| US-4001426-A | HAVING CORONARY VASODILATOR ACTIVITY | SMITHKLINE CORPORATION (US) | 1977-01-04 | — | — | US | disclosed |
| US-3996210-A | OPTICAL BRIGHTENERS | SANDOZ LTD. (CH) | 1976-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11306053-B2 | Ester compound and lubricating oil base oil | F12, ELOVL1, HRH1 | CA2 3488/4885DRD1 490/4885GAA 4393/4885 |
| US-11802258-B2 | Perfume precursor | CYP2E1, ADH1A, CYP1A1 | CA2 3624/4885DRD1 256/4885GAA 4538/4885 |
| US-12030836-B2 | Phenyl isocyanate conversion process | UROD, HPD, UBE2I | CA2 3133/4885DRD1 37/4885GAA 3967/4885 |
| US-20220106264-A1 | PHENYL ISOCYANATE CONVERSION PROCESS | UROD, HPD, UBE2I | CA2 3133/4885DRD1 37/4885GAA 3967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.